Research debunks long-held psychology traditions and mental health myths
New research challenges traditional views and myths in psychology, such as the long-held belief that parenting is the biggest influence on adult personalities.
May 7, 2025
0
39
MeSH tree: D27.505.954.427.700
New research challenges traditional views and myths in psychology, such as the long-held belief that parenting is the biggest influence on adult personalities.
May 7, 2025
0
39
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
May 6, 2025
0
18
Psychotherapy assumed a larger role in outpatient mental health care while psychiatric medication without psychotherapy became less common, according to a study at Columbia University Mailman School of Public Health and Columbia ...
May 1, 2025
0
29
Mass General Brigham researchers found that interactions between immune and brain cells drive fear responses, but treatment with psychedelics like MDMA and psilocybin may reverse these effects.
Apr 23, 2025
0
220
A multisource observational study aimed to quantify the change in prevalence and health care utilization of psilocybin users between 2014 and 2023. The study found that the prevalence of psilocybin use increased across all ...
Apr 21, 2025
0
84
Exposure time to antidepressants in adults is associated with a higher risk for sudden cardiac death (SCD), according to a study presented at the annual meeting of the European Heart Rhythm Association, held from March 30 ...
Apr 16, 2025
0
17
Patients with depression who received the Moodivate app saw clinically meaningful reductions in their symptoms that were twice those achieved with standard-of-care therapy in a clinical trial conducted at 22 primary care ...
Apr 14, 2025
0
29
Psychotropic medicines commonly prescribed for older people in aged care homes to treat mental health conditions need to be reviewed because they may cause loss of balance and lead to unnecessary falls and injuries, researchers ...
Apr 11, 2025
0
16
Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to treating schizophrenia, which affects an estimated 3.7 million American adults. The drug is now beginning ...
Apr 7, 2025
0
462
With cannabis and hallucinogen use on the rise, the Michigan Society of Anesthesiologists is trying to educate the public on the importance of disclosing the use of the substances to physicians, particularly before going ...
Apr 7, 2025
0
18